NO20033318D0 - 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav - Google Patents

2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav

Info

Publication number
NO20033318D0
NO20033318D0 NO20033318A NO20033318A NO20033318D0 NO 20033318 D0 NO20033318 D0 NO 20033318D0 NO 20033318 A NO20033318 A NO 20033318A NO 20033318 A NO20033318 A NO 20033318A NO 20033318 D0 NO20033318 D0 NO 20033318D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
manufacture
benzopyran derivatives
preparation
benzopyran
Prior art date
Application number
NO20033318A
Other languages
English (en)
Other versions
NO20033318L (no
NO327808B1 (no
Inventor
Maurizio Delcanale
Gabriele Amari
Elisabetta Armani
Maurizio Civelli
Elisabetta Galbiati
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01101521A external-priority patent/EP1229036B1/en
Priority claimed from EP01118682A external-priority patent/EP1281710A1/en
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20033318D0 publication Critical patent/NO20033318D0/no
Publication of NO20033318L publication Critical patent/NO20033318L/no
Publication of NO327808B1 publication Critical patent/NO327808B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO20033318A 2001-01-24 2003-07-23 2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav NO327808B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01101521A EP1229036B1 (en) 2001-01-24 2001-01-24 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en) 2001-08-03 2001-08-03 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
PCT/EP2002/000567 WO2002059113A1 (en) 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (3)

Publication Number Publication Date
NO20033318D0 true NO20033318D0 (no) 2003-07-23
NO20033318L NO20033318L (no) 2003-09-24
NO327808B1 NO327808B1 (no) 2009-09-28

Family

ID=26076450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033318A NO327808B1 (no) 2001-01-24 2003-07-23 2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav

Country Status (27)

Country Link
US (1) US6951883B2 (no)
EP (1) EP1355906B1 (no)
JP (1) JP4332349B2 (no)
CN (1) CN1261431C (no)
AT (1) ATE286894T1 (no)
AU (1) AU2002237282B2 (no)
BR (1) BR0207066A (no)
CA (1) CA2435775A1 (no)
CZ (1) CZ20032014A3 (no)
DE (1) DE60202590T2 (no)
DK (1) DK1355906T3 (no)
DZ (1) DZ3459A1 (no)
EA (1) EA006158B1 (no)
ES (1) ES2236485T3 (no)
HK (1) HK1060558A1 (no)
HU (1) HUP0401018A3 (no)
IL (2) IL157065A0 (no)
MA (1) MA26982A1 (no)
MX (1) MXPA03006505A (no)
NO (1) NO327808B1 (no)
NZ (1) NZ527144A (no)
PL (1) PL365062A1 (no)
PT (1) PT1355906E (no)
SI (1) SI1355906T1 (no)
SK (1) SK287086B6 (no)
TN (1) TNSN03043A1 (no)
WO (1) WO2002059113A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
AU2005201855B2 (en) * 2004-09-21 2012-03-29 Marshall Edwards, Inc. Chroman derived compounds and formulations thereof for use in therapy
WO2006032086A1 (en) * 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
ES2516067T3 (es) * 2004-09-21 2014-10-30 Mei Pharma, Inc. Derivados de cromano sustituidos, medicamentos y utilización en terapia
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN101444499B (zh) * 2007-11-26 2012-12-05 湘北威尔曼制药股份有限公司 一种化合物及其组合物的新用途
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
SG11201509508YA (en) 2013-06-19 2015-12-30 Seragon Pharmaceuticals Inc Estrogen receptor modulator and uses thereof
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies
JP6946430B2 (ja) * 2016-11-17 2021-10-06 サノフイＳａｎｏｆｉ 新規の置換ｎ−（３−フルオロプロピル）−ピロリジン化合物、それを製造するための方法、およびその治療的使用
US20200215025A1 (en) * 2017-09-15 2020-07-09 Norbio No. 1 Pty Ltd Treatment of excitotoxicity
CN112225716A (zh) * 2020-10-30 2021-01-15 陕西嘉禾生物科技股份有限公司 一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374245A (en) * 1964-04-01 1968-03-19 Ciba Geigy Corp Unsaturated oxacycles
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en) 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
ZA979643B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
EP0944613B1 (en) 1996-12-13 2002-10-09 Chugai Seiyaku Kabushiki Kaisha Benzopyran derivatives
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
WO2000039120A2 (en) * 1998-12-30 2000-07-06 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors

Also Published As

Publication number Publication date
US6951883B2 (en) 2005-10-04
DE60202590T2 (de) 2005-12-29
SK9392003A3 (en) 2003-12-02
MXPA03006505A (es) 2004-04-21
HK1060558A1 (en) 2004-08-13
MA26982A1 (fr) 2004-12-20
CZ20032014A3 (cs) 2003-12-17
HUP0401018A2 (hu) 2004-09-28
IL157065A (en) 2010-05-17
CN1487934A (zh) 2004-04-07
AU2002237282B2 (en) 2007-02-15
JP2004517151A (ja) 2004-06-10
EP1355906A1 (en) 2003-10-29
PT1355906E (pt) 2005-05-31
TNSN03043A1 (en) 2005-12-23
SK287086B6 (sk) 2009-11-05
NO20033318L (no) 2003-09-24
EP1355906B1 (en) 2005-01-12
EA200300727A1 (ru) 2004-02-26
HUP0401018A3 (en) 2007-05-29
NZ527144A (en) 2005-03-24
DZ3459A1 (fr) 2002-08-01
CN1261431C (zh) 2006-06-28
CA2435775A1 (en) 2002-08-01
WO2002059113A1 (en) 2002-08-01
JP4332349B2 (ja) 2009-09-16
DK1355906T3 (da) 2005-05-30
ES2236485T3 (es) 2005-07-16
IL157065A0 (en) 2004-02-08
ATE286894T1 (de) 2005-01-15
NO327808B1 (no) 2009-09-28
PL365062A1 (en) 2004-12-27
EA006158B1 (ru) 2005-10-27
BR0207066A (pt) 2004-03-30
DE60202590D1 (de) 2005-02-17
US20040106595A1 (en) 2004-06-03
SI1355906T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
WO2003080582A3 (de) Fredericamycin-derivate
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NL300305I1 (nl) Werkwijze voor de bereiding van gesubstitueerde octanoylamides.
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
MXPA04003636A (es) Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato.
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2003033557A3 (de) Fluorhaltige copolymere, deren herstellung und verwendung
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
AP2001002369A0 (en) Pharmaceutical complex.
ATE286893T1 (de) 2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
EP1436279B8 (en) Chemical compounds
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
CA2420056A1 (en) 1-amino-alkylcyclohexanes as trypanocidal agents
WO2003064394A8 (de) 5-ring heterozyklen zur verwendung als antiviral mittel
MXPA03008636A (es) Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
ZA200308097B (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees